Celgene Corporation : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

iCD Research
April 21, 2013
44 Pages - SKU: ICDR5021529
Celgene Corporation : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

Synopsis

ICD Research's Celgene Corporation : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.

Summary

This report is a crucial resource for industry executives and anyone looking to access key information about Celgene Corporation

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Celgene Corporation for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Celgene Corporation
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Celgene Corporation (Celgene) is an integrated biopharmaceutical company, which primarily focuses on the research, development, manufacture, and marketing of therapies for the treatment of cancer and immune-inflammatory-related diseases. The company's commercial stage products include REVLIMID, VIDAZA, ABRAXANE, THALOMID and ISTODAX. The company also receives royalties from Novartis Pharma AG upon sales of FOCALIN XR and the entire RITALIN family of drugs. The company operates in more than 50 countries and sells its products in over 70 countries across North America, Europe, Latin America, the Middle East, and Asia-Pacific. Celgene is headquartered in Summit (New Jersey), the US.



More C - Companies reports by iCD Research

Cap Gemini S.A. : Technology and Communications - Company Profile, SWOT & Financial Report by iCD Research
Cap Gemini S.A. : Technology and Communications - Company Profile, SWOT & Financial Report Synopsis ICD Research's ""Cap Gemini S.A. : Technology and Communications - ...
CA, Inc. : Technology and Communications - Company Profile, SWOT & Financial Report by iCD Research
CA, Inc. : Technology and Communications - Company Profile, SWOT & Financial Report Synopsis ICD Research's ""CA, Inc. : Technology and Communications - Company Profile, ...
Cognizant Technology Solutions Corp. : Technology and Communications - Company Profile, SWOT & Financial Report by iCD Research
Cognizant Technology Solutions Corp. : Technology and Communications - Company Profile, SWOT & Financial Report Synopsis ICD Research's ""Cognizant Technology Solutions Corp. : Technology and ...
Computer Sciences Corporation : Technology and Communications - Company Profile, SWOT & Financial Report by iCD Research
Computer Sciences Corporation : Technology and Communications - Company Profile, SWOT & Financial Report Synopsis ICD Research's ""Computer Sciences Corporation : Technology and Communications - ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 125  
    Site License  USD 250  
    Global Site License  USD 375  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!